GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now gaining a significant focus in medical research, largely due to its remarkable impact on controlling ailments such as second type diabetes and excess body fat. Recent trials have shown that in addition to glucose regulation, GLP-1 medications offer benefits for circulatory function